Filing Details

Accession Number:
0001209191-14-045478
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-02 18:20:30
Reporting Period:
2014-06-30
Filing Date:
2014-07-02
Accepted Time:
2014-07-02 18:20:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113148 Infinity Pharmaceuticals Inc. INFI Pharmaceutical Preparations (2834) 330655706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492805 J. Vito Palombella C/O Infinity Pharmaceuticals, Inc.
780 Memorial Drive
Cambridge MA 02139
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-30 879 $10.83 879 No 5 A Direct
Common Stock Disposition 2014-07-01 879 $12.87 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,147 Indirect By 401k
Footnotes
  1. The acquisition represents shares purchased through participation in the issuer's Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(c) and Rule 16b-3(d).
  2. The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.78 to $13.02, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3.